Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4141467 | Anales de Pediatría | 2015 | 5 Pages |
Abstract
Cytomegalovirus infection is common in cardiac transplant patients. Foscarnet is used, with limited evidence, as second-line treatment after ganciclovir failure in these patients. We describe the case of a paediatric cardiac transplant patient who developed electrolyte disturbances during foscarnet treatment for cytomegalovirus infection. The infection resolved after 6 weeks of treatment. Low ionized calcium and magnesium levels were observed during the drug infusion, which were treated with supplements. The serum levels reverted to normal after drug withdrawal.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
M.B. Marzal-Alfaro, S. Manrique-RodrÃguez, A. Alcaraz Romero, M. GarcÃa San Prudencio, C.M. Fernández-Llamazares,